Supporting Rare Diseases Research.
We support "Rare Partners" organization every year with their activities, both directly with charity projects and participating to different social awareness initiatives to sensitize the community to both childhood and adulthood Rare Diseases.
Promoting Rare Partners testimonials' campaigns worldwide
"L'Occhio di Ale"
Together with Alessandro Mennella and Rare Partners against Usher's Syndrome
Usher's Syndrome is a rare genetic disease, leading to progressive deafness and blindness. Most of people are not aware of the disease nor of the daily challenges for people for those who are born with it. For this reason, we made our offices in Italy available to host a travelling exhibition to sensitize clients, employees and community to this important topic. The project is a collaboration with Alessandro Mennella and Rare Partners.
Rare Partners Charity Program
As partnering brand, we participate to numerous sports and cultural events part of Rare Partners' Charity Program during the entire year. Delegations of PQE employees are usually invited to take part to these events to raise awareness and help funding the activities of Rare Partners organization.
Our institutional Partner:
Rare Partners is a non profit company, founded in March 2010, with the aim to support the development of new therapies and diagnostics in the field of rare diseases. The basic idea behind our initiative is that of matching non profit (private and public) financial resources with industrial drug development expertise, which will be provided by Rare Partners’ organization. Their mission is supporting the development of new therapies and diagnostics in the field of rare diseases, with the basic idea of matching non profit (private and public) financial resources with industrial drug development expertise, which we provide through our organization and network of consultants with great experience, know-how and personal commitment. All their activities are not business driven, but rather pulled by the need of medicals present in the rare disease field.